Merck (MRK) Total Current Liabilities (2009 - 2026)

Merck has disclosed Total Current Liabilities across 18 years of filings, most recently posting $26.9 billion for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 7.04% year-over-year to $26.9 billion; the TTM figure through Mar 2026 stood at $26.9 billion (up 7.04% YoY), while the FY2025 annual figure was $28.3 billion, changed 0.33% from the prior year.
• Total Current Liabilities retreated to $26.9 billion in Q1 2026, from $28.3 billion in the prior quarter.
• Over the last five years, Total Current Liabilities for MRK reached as high as $29.6 billion in Q3 2024 and fell as low as $22.3 billion in Q1 2022.
• The 5-year median for Total Current Liabilities is $25.2 billion (2025), against an average of $25.4 billion.
• Annual changes were most pronounced in 2022 — Total Current Liabilities slipped 15.34% — and 2024, when it grew 28.11%.
• A 5-year view of Total Current Liabilities shows it stood at $24.2 billion in 2022, then advanced by 6.0% to $25.7 billion in 2023, then rose by 10.61% to $28.4 billion in 2024, then decreased by 0.33% to $28.3 billion in 2025, then slipped by 4.88% to $26.9 billion in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $26.9 billion, $28.3 billion, and $28.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.